Chronomics Competitors and Similar CompaniesClear all
Chronomics's competitors and similar companies include Storm Therapeutics, Oxford Biodynamics, Cambridge Epigenetix and Horizon Discovery.
 Storm Therapeutics Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. |  Oxford Biodynamics Oxford BioDynamics Plc, a biotechnology company, discovers and develops novel biomarkers. |  Cambridge Epigenetix Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw. |  Horizon Discovery Horizon Discovery Group is a company that supplies genetically defined cell lines, in vivo models, reference standards, and contract research services to academia and biopharma. | ||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2007 | Founding Date 2012 | Founding Date 2005 |
Type | Type Private | Type Private | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Norwich, GB HQ Norwich, GB | Locations Cambridge, GB HQ Greater London, GB | Locations Oxford, GB HQ George Town, MY Halesowen, GB London, GB Oxford, GB Stratford Upon Avon, GB New York, US | Locations Little Chesterford, GB HQ Wilmslow, GB | Locations Waterbeach, GB HQ Boyertown, US Lafayette, US St. Louis, US |
Employees | Employees 572% decrease | Employees 327% increase | Employees 51 | Employees 1121% decrease | Employees 114 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) £1.1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) £62.9m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods £573k (FY, 2025) | Cost of goods N/A | Cost of goods £12.6m (FY, 2019) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit £551k (FY, 2025) | Gross profit N/A | Gross profit £52.3m (FY, 2019) |
Net income | Net income N/A | Net income N/A | Net income (£11.2m) (FY, 2025) | Net income (£86.2k) (FY, 2012) | Net income (£4.6m) (FY, 2019) |
Funding | |||||
Latest funding round | Latest funding round $ 1.4m (over 7 years ago) | Latest funding round $ 5.4m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 30m (about 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 21.4m | Total funding raised N/A | Total funding raised $ 56.5m | Total funding raised $ 50.2m |
For sources of this data, please see the company profile
View Company Profiles
Storm Therapeutics
HQ
Cambridge, GB
Employees
32↑ 7% increase
Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer.
View companyOxford Biodynamics
HQ
Oxford, GB
Employees
51
Oxford BioDynamics Plc, a biotechnology company, discovers and develops novel biomarkers.
View companyCambridge Epigenetix
HQ
Little Chesterford, GB
Employees
112↓ 1% decrease
Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
View companyHorizon Discovery
HQ
Waterbeach, GB
Horizon Discovery Group is a company that supplies genetically defined cell lines, in vivo models, reference standards, and contract research services to academia and biopharma.
View company